DanCann Pharma A/S’ shares commence trading on the OTCQB venture market in the United States
COPENHAGEN, Denmark, 5 December 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby announces that the Company has been welcomed by OTC Markets Group for trading on OTCQB in the US - an important step for DanCann Pharma into the US capital markets improving access for US-Investors to DCPXF-shares.DanCann Pharma has been approved and qualified to trade on the OTCQB Venture Market under the symbol "DCPXF". OTC Markets Group is an operator of regulated markets for trading 12,000 US and international securities providing